Subscribe

Mouwasat Medical Services Company (4002.SR)

SAR60.75 -0.60 (-0.98%)
SA SAU Healthcare Medical - Care Facilities
Address Destect 71 - King Fahad Road 31411
Dammam, Eastern Province, SA
CEO Nasser Sultan Al-Hammad Al-Subaie
Website mouwasat.com
IPO 2010-02-22
ISIN SA12C051UH11

Explore sections of this company profile

Description

Mouwasat Medical Services Company, established in 1974 and headquartered in Dammam, Saudi Arabia, is a prominent healthcare provider. The company's core activities involve the acquisition, management, and operation of a wide array of medical facilities, including hospitals, clinics, pharmacies, and drugstores throughout the Kingdom of Saudi Arabia. Mouwasat operates an extensive chain of hospitals located in key cities such as Dammam, Jubail, Madinah, Khobar, Qatif, and Riyadh, delivering comprehensive medical care to its patients. Beyond general hospital services, the company features specialized centers addressing various health needs. These include dedicated skin care facilities offering cosmetic dermatology, laser treatments, reconstructive and plastic surgery, beauty services, and weight loss programs. It also provides a fertility center and a specialized clinic for bariatric surgery. Further expanding its specialized offerings, Mouwasat boasts a cardiology center for the diagnosis and treatment of heart conditions, a dedicated stroke unit, and a facility focused on managing diabetes and diabetic foot complications. The company also extends its services to include long-term care and rehabilitation. Additionally, Mouwasat Medical Services Company is active in the wholesale distribution of medical equipment and pharmaceutical products.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
SAR60.75 -0.60 (-0.98%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
366.9K
Beta
0.07
Float Shares
90.76M
Free Float %
45.4%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-1.13% -3.10% -7.13% -4.29% -9.25% -1.35% -16.35% -45.21% -31.72% +100.76% +906.89%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
60.75
DCF (Unlevered) 392.85 +546.7%
DCF (Levered) 884.50 +1,356.0%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 45% Bullish
Rating 2026-05 Change
Strong Buy 1 0
Buy 4 0
Hold 5 -1
Sell 1 0
Strong Sell 0 0
Quality scores
Altman Z-Score
4.72
Safe zone
Piotroski F-Score
6 / 9
Average
MOAT Score
7 / 10
Strong MOAT
Composite Rating
A
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Care Facilities: +10.2%
    +11.9% ★ Q1'26: +9.1% (vs Q1'25)
  • ✓
    EPS growth Medical - Care Facilities: +19.2%
    +26.9% ★ Q1'26: +2.0% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Medical - Care Facilities: +32.0%
    +28.4% Q1'26: +15.2% (vs Q1'25)
  • ✓
    EBIT margin Medical - Care Facilities: +11.3%
    +27.0% ★ Q1'26: +25.2% (vs Q1'25)
  • ✓
    ROIC Medical - Care Facilities: +6.8%
    +19.0% ★ Q1'26: +17.6% (vs Q1'25)
  • ✗
    Share dilution Medical - Care Facilities: +0.0%
    +0.0% Q1'26: -0.5% (vs Q1'25)
  • ✓
    Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×
    0.89× ★ Q1'26: 1.02× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.10) × ERP
WACC = 93% × Ke + 7% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 371.40 Current price: 60.75
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2015
actual 		Dec 2016
actual 		Dec 2017
actual 		Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
8 Rev. Ana.
6 EPS Ana. 		Dec 2027
9 Rev. Ana.
8 EPS Ana. 		Dec 2028
3 Rev. Ana.
7 EPS Ana. 		Dec 2029
4 Rev. Ana.
6 EPS Ana. 		Dec 2030
4 Rev. Ana.
6 EPS Ana.
Revenue
1.00B
est: 1.08B (-7.6%)
1.24B
est: 1.22B (+2.0%)
1.51B
est: 1.46B (+3.0%)
1.68B
est: 1.74B (-3.5%)
1.86B
est: 1.83B (+1.7%)
2.05B
est: 2.06B (-0.7%)
2.14B
est: 2.16B (-0.8%)
2.33B
est: 2.28B (+2.2%)
2.71B
est: 2.83B (-4.3%)
2.88B
est: 2.94B (-1.9%)
3.22B
est: 3.17B (+1.8%)
3.64B
3.60B – 3.66B
+14.9% YoY
4.01B
3.73B – 4.40B
+10.3% YoY
4.32B
4.14B – 4.55B
+7.7% YoY
4.73B
4.53B – 4.98B
+9.5% YoY
5.00B
4.79B – 5.26B
+5.6% YoY
EBITDA
289.23M
est: 388.38M (-25.5%)
376.26M
est: 437.88M (-14.1%)
463.09M
est: 525.19M (-11.8%)
521.18M
est: 623.86M (-16.5%)
615.43M
est: 655.18M (-6.1%)
726.18M
est: 739.07M (-1.7%)
779.42M
est: 776.10M (+0.4%)
861.82M
est: 820.12M (+5.1%)
997.02M
est: 1.01B (-1.2%)
974.25M
est: 1.05B (-7.0%)
1.11B
est: 1.13B (-1.4%)
1.30B
1.29B – 1.31B
+14.9% YoY
1.43B
1.33B – 1.57B
+10.3% YoY
1.54B
1.48B – 1.62B
+7.7% YoY
1.69B
1.62B – 1.78B
+9.5% YoY
1.78B
1.71B – 1.88B
+5.6% YoY
EBIT
246.59M
est: 303.55M (-18.8%)
288.06M
est: 342.23M (-15.8%)
384.44M
est: 410.47M (-6.3%)
404.06M
est: 487.59M (-17.1%)
470.49M
est: 512.06M (-8.1%)
577.84M
est: 577.63M (+0.0%)
621.93M
est: 606.57M (+2.5%)
683.15M
est: 640.97M (+6.6%)
773.54M
est: 785.87M (-1.6%)
736.25M
est: 815.93M (-9.8%)
869.46M
est: 879.91M (-1.2%)
1.01B
1.00B – 1.02B
+14.9% YoY
1.12B
1.04B – 1.22B
+10.3% YoY
1.20B
1.15B – 1.26B
+7.7% YoY
1.32B
1.26B – 1.38B
+9.5% YoY
1.39B
1.33B – 1.46B
+5.6% YoY
Net Income
208.80M
est: 211.04M (-1.1%)
255.88M
est: 248.87M (+2.8%)
336.73M
est: 323.06M (+4.2%)
360.21M
est: 366.25M (-1.7%)
421.03M
est: 382.35M (+10.1%)
528.16M
est: 532.10M (-0.7%)
578.16M
est: 573.26M (+0.9%)
599.31M
est: 569.29M (+5.3%)
657.69M
est: 664.82M (-1.1%)
645.76M
est: 705.50M (-8.5%)
822.04M
est: 774.20M (+6.2%)
817.02M
798.98M – 851.13M
+5.5% YoY
925.00M
847.43M – 1.05B
+13.2% YoY
1.00B
947.45M – 1.07B
+8.3% YoY
1.13B
1.07B – 1.21B
+12.6% YoY
1.26B
1.19B – 1.35B
+11.5% YoY
SGA
29.95M
est: 42.99M (-30.3%)
42.23M
est: 48.47M (-12.9%)
57.67M
est: 58.14M (-0.8%)
61.56M
est: 69.06M (-10.9%)
85.68M
est: 72.53M (+18.1%)
77.05M
est: 81.81M (-5.8%)
78.47M
est: 85.91M (-8.7%)
99.37M
est: 90.78M (+9.5%)
123.31M
est: 114.49M (+7.7%)
104.35M
est: 118.87M (-12.2%)
133.75M
est: 128.19M (+4.3%)
147.28M
145.93M – 148.04M
+14.9% YoY
162.52M
150.97M – 178.01M
+10.3% YoY
175.01M
167.68M – 184.25M
+7.7% YoY
191.61M
183.58M – 201.73M
+9.5% YoY
202.37M
193.89M – 213.06M
+5.6% YoY
EPS
1.05
est: 1.06 (-0.5%)
1.29
est: 1.24 (+3.7%)
1.69
est: 1.62 (+4.6%)
1.80
est: 1.83 (-1.7%)
2.11
est: 1.91 (+10.4%)
2.64
est: 2.66 (-0.8%)
2.89
est: 2.87 (+0.8%)
3.00
est: 2.85 (+5.1%)
3.29
est: 3.32 (-1.0%)
3.24
est: 3.53 (-8.3%)
4.11
est: 3.87 (+6.2%)
4.12
3.99 – 4.26
+6.5% YoY
4.64
4.24 – 5.27
+12.5% YoY
5.01
4.74 – 5.35
+8.0% YoY
5.64
5.34 – 6.03
+12.6% YoY
6.30
5.95 – 6.73
+11.5% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-11 A 4/5 5/5 5/5 5/5 2/5 3/5 2/5
2026-05-10 C+ 2/5 5/5 1/5 1/5 1/5 3/5 1/5
2026-05-07 C+ 2/5 5/5 1/5 1/5 1/5 3/5 1/5
2026-05-06 C+ 2/5 5/5 1/5 1/5 1/5 3/5 1/5
2026-05-05 C+ 2/5 5/5 1/5 1/5 1/5 3/5 1/5
2026-05-04 C+ 2/5 5/5 1/5 1/5 1/5 3/5 1/5
2026-05-03 C+ 2/5 5/5 1/5 1/5 1/5 3/5 1/5
2026-04-30 A 4/5 5/5 5/5 5/5 2/5 3/5 2/5
2026-04-29 A 4/5 5/5 5/5 5/5 2/5 3/5 2/5
2026-04-28 A 4/5 5/5 5/5 5/5 2/5 3/5 2/5
2026-04-27 A 4/5 5/5 5/5 5/5 2/5 3/5 2/5
2026-04-26 A 4/5 5/5 5/5 5/5 2/5 3/5 2/5
2026-04-23 A- 4/5 5/5 5/5 5/5 1/5 3/5 2/5
2026-04-22 A- 4/5 5/5 5/5 5/5 1/5 3/5 2/5
2026-04-21 A- 4/5 5/5 5/5 5/5 1/5 3/5 2/5
2026-04-20 A- 4/5 5/5 5/5 5/5 1/5 3/5 2/5
2026-04-19 A- 4/5 5/5 5/5 5/5 1/5 3/5 2/5
2026-04-16 A- 4/5 5/5 5/5 5/5 1/5 3/5 2/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
1.02B
OE per share TTM
5.29
Owner's Yield
7.71%
Maintenance CapEx ratio
0.64%
Maint CapEx / Avg PPE
119.0%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 114 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 Invesco MSCI Saudi Arabia UCITS ETF MSAU.L 0.52% 242.9K 0.50%
2 iShares MSCI Saudi Arabia ETF KSA 0.50% 3.24M 0.75%
3 iShares MSCI Saudi Arabia Capped UCITS ETF IKSA.L 0.50% 2.57M 0.60%
4 iShares MSCI Saudi Arabia Capped UCITS ETF IKSD.L 0.50% 95.7K 0.60%
5 VanEck - MSCI Multifactor Emerging Markets Equity ETF EMKT.AX 0.12% 626.8K 0.69%
6 Franklin EM Multi-Factor Equity UCITS ETF FREM.L 0.08% 71.0K 0.30%
7 iShares MSCI EM Consumer Growth UCITS ETF CEMG.L 0.07% 30.2K 0.60%
8 BMO Low Volatility Emerging Markets Equity ETF ZLE.TO 0.06% 43.3K 0.51%
9 iShares MSCI Emerging Markets Quality Factor ETF EQLT 0.04% 5.2K 0.35%
10 Fidelity Emerging Markets Equity Research Enhanced UCITS ETF ACC-USD FEMR.L 0.04% 1.84M 0.30%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
212.9K
Shares Outstanding
200.00M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Khaled Bin Suleiman Al-Saleem MD & Executive Director 756.0K male
Nasser Sultan Al-Hammad Al-Subaie Vice-Chairman & Chief Executive Officer 756.0K male
Ahmed Abdulfattah Touman Chief Pharmacist — —
Yusuf Ahmad Sulaiman Board of Director's Secretary & Chief Financial Officer — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Care Facilities